Diagnosing Oncocytoma by Core Needle Biopsy: A Single-Center Experience.
Journal
Advances in urology
ISSN: 1687-6369
Titre abrégé: Adv Urol
Pays: Egypt
ID NLM: 101476240
Informations de publication
Date de publication:
2022
2022
Historique:
received:
01
02
2022
revised:
23
07
2022
accepted:
05
08
2022
entrez:
8
9
2022
pubmed:
9
9
2022
medline:
9
9
2022
Statut:
epublish
Résumé
Oncocytoma is one of the most common benign kidney tumors, accounting for 3-7% of all solid renal masses. Diagnosing oncocytomas using renal biopsy remains a controversy in the uro-pathologic community. With the increasing use of biopsies for assessment of renal lesions, reaching this pathologically benign diagnosis may prevent further surgical measures and have significant clinical benefit. To demonstrate our center's results using renal biopsy to diagnose oncocytomas and to suggest that this diagnosis can be made with high success rates. , Our study demonstrates that with good patient selection and proficient cooperation between urologists, radiologists and dedicated uro-pathologists, correctly diagnosing oncocytomas using RCB is a viable task.
Sections du résumé
Background
UNASSIGNED
Oncocytoma is one of the most common benign kidney tumors, accounting for 3-7% of all solid renal masses. Diagnosing oncocytomas using renal biopsy remains a controversy in the uro-pathologic community. With the increasing use of biopsies for assessment of renal lesions, reaching this pathologically benign diagnosis may prevent further surgical measures and have significant clinical benefit.
Objective
UNASSIGNED
To demonstrate our center's results using renal biopsy to diagnose oncocytomas and to suggest that this diagnosis can be made with high success rates.
Design
UNASSIGNED
,
Conclusions
UNASSIGNED
Our study demonstrates that with good patient selection and proficient cooperation between urologists, radiologists and dedicated uro-pathologists, correctly diagnosing oncocytomas using RCB is a viable task.
Identifiants
pubmed: 36071862
doi: 10.1155/2022/1589040
pmc: PMC9444412
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1589040Informations de copyright
Copyright © 2022 Chen Mayer et al.
Déclaration de conflit d'intérêts
The authors declare that they have no conflicts of interest.
Références
JAMA Surg. 2019 Mar 1;154(3):225-231
pubmed: 30516801
J Urol. 2016 Mar;195(3):568-73
pubmed: 26410732
Eur Urol. 2015 Dec;68(6):1007-13
pubmed: 25900781
Histopathology. 2011 Jan;58(2):169-79
pubmed: 21323945
BJU Int. 2012 Nov;110(10):1444-8
pubmed: 22520366
J Mol Diagn. 2010 Sep;12(5):687-96
pubmed: 20595629
Clin Radiol. 2011 Nov;66(11):1007-14
pubmed: 21784421
J Urol. 1999 Jul;162(1):40-2
pubmed: 10379735
Cancers (Basel). 2020 Jan 09;12(1):
pubmed: 31936678
Arch Pathol Lab Med. 2014 Dec;138(12):1673-9
pubmed: 25427045
J Urol. 2007 Aug;178(2):379-86
pubmed: 17561170
J Urol. 2016 Mar;195(3):581-6
pubmed: 26388501
Appl Immunohistochem Mol Morphol. 2019 May/Jun;27(5):e48-e53
pubmed: 28682831
Cancer. 1962 Sep-Oct;15:1019-27
pubmed: 13904230
J Urol. 2008 Oct;180(4):1257-61; discussion 1261
pubmed: 18707712
Eur Urol. 2011 Sep;60(3):578-84
pubmed: 21704449
Histol Histopathol. 2013 Oct;28(10):1257-64
pubmed: 23740406
Am J Surg Pathol. 1997 Jan;21(1):1-12
pubmed: 8990136
Cancer Control. 1999 Nov;6(6):571-579
pubmed: 10756388
Hum Pathol. 1984 Nov;15(11):1054-61
pubmed: 6490001
Virchows Arch B Cell Pathol Incl Mol Pathol. 1988;56(3):185-9
pubmed: 2464871
Int J Urol. 2010 Jul;17(7):602-12
pubmed: 20590944
Am J Surg Pathol. 2011 Jul;35(7):949-61
pubmed: 21677535
Cancer. 2004 Feb 15;100(4):738-45
pubmed: 14770429
Urology. 2005 Dec;66(6):1181-5
pubmed: 16360437
J Urol. 2003 Dec;170(6 Pt 1):2217-20
pubmed: 14634382
J Clin Pathol. 2007 Jun;60(6):720-2
pubmed: 17557872
Arkh Patol. 2007 Sep-Oct;69(5):34-6
pubmed: 18074818
Urology. 1983 Oct;22(4):355-9
pubmed: 6636388